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Abstract In lower and higher eukaryotes, a family of tightly
related proteins designated eRF1 (for eukaryotic release factor
1) catalyses termination of protein synthesis at all three stop
codons. The human genome contains four eRF1 homologous
sequences localised on chromosomes 5, 6, 7 and X. We report
here the cloning and the structural analysis of the human eRF1
gene family. It appears that the gene located on chromosome 5
alone is potentially functional, whereas the other three sequences
resemble processed pseudogenes. This is the first description of
the structural organisation of the human eRF1 gene, which has
been remarkably conserved during evolution and which is
essential in the translation termination process.
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1. Introduction
Termination of protein synthesis occurs when a stop codon
enters the A site of the ribosome. Hydrolysis of the last pep-
tidyl tRNA, liberating the nascent polypeptide, requires spe-
ci¢c release factors (RFs) and GTP [1,2]. In higher eukary-
otes, it was reported over 20 years ago that a single release
factor can recognise all three nonsense codons in an in vitro
GTP-dependent termination assay [3]. This factor has been
characterised as a member of a highly conserved protein fam-
ily and designated eRF1 for eukaryotic release factor 1 [4]. No
member of the eRF1 protein family contained GTP-binding
motifs known to be present in proteins involved in GTP-de-
pendent reactions, however, so it was suggested that an addi-
tional eRF should exist that confers GTP requirement for the
termination process [4]. It has been demonstrated [5] that a
second polypeptide factor exists, named eRF3, which is inac-
tive per se as a release factor, but which can interact with
eRF1 and greatly stimulate its activity in the presence of
GTP and low stop codon concentration. These authors sug-
gested that a quaternary complex composed of eRF1, eRF3,
GTP and the ribosome was the catalytically active termination
complex. It was then shown that eRF3, which displays GTP-
binding motifs in its structure [5], is a GTPase with negligible
intrinsic activity, but that it is greatly stimulated by the con-
comitant presence of eRF1 and the ribosome [6]. The N-ter-
minal fragment of eRF3 proteins in higher eukaryotes proved
to be non-essential for GTP binding [6] and furthermore,
GTPase and eRF1-stimulating activities of the truncated
eRF3 proteins are preserved [5,7]. The molecular anatomy
of interaction between the two human eRFs was characterised
in vivo [8] ; it was shown that in each factor, two regions in
the C-terminal parts are critical for reciprocal binding, and
that GTP and eRF1 binding regions of eRF3 are non-over-
lapping.
The mechanisms by which eRF1 and eRF3 act in the ter-
mination process are not yet clearly understood. In the case of
eRF1, stop-signal recognition involved protein-RNA recogni-
tion instead of mRNA codon-tRNA anticodon pairing (re-
viewed in [9,10]). A model of molecular mimicry between
release factors and tRNA has been proposed [11], assuming
that a domain in the RF protein structure could recognise the
stop codon. It has also been suggested that an e⁄cient stop
signal might be more than just the codon (reviewed in [12,13]).
The authors concluded that the +4 base nature in£uenced the
e⁄ciency with which the stop codon was decoded, and that
the two bases immediately downstream could also have sig-
ni¢cant e¡ects. The resulting hierarchy of e⁄ciencies for stop
signals could play a role in competition at the signal, and thus
be important in the regulation of certain cellular events [12].
Hypotheses about the role(s) of eRF3 have also been formu-
lated. In a ‘GTP state’, eRF3 should control the positioning
of eRF1 towards the ribosome, while in a ‘GDP state’, it
should facilitate the dissociation of the eRFs from the ribo-
some [6]. The RF-tRNA mimicry model also predicted that
eRF3 should mimic an EF-Tu function and bring eRF1 to the
A site of the ribosome for termination of the protein synthesis
(reviewed in [10]). Additional roles have been postulated for
eRF3 (reviewed in [14]) : recycling of eRF1 and the ribosome
at the end of the translation termination process [9,10] and a
proof-reading function [10]. Although some hypotheses have
not yet been experimentally con¢rmed, important progress in
understanding the roles of eRF1 and eRF3 proteins has been
made.
Numerous cDNAs encoding eRF1 protein have been de-
scribed in higher eukaryotes: one from Xenopus laevis, Cl1
[15], two from Syrian hamster, MACl1-4 and MACl1-1 [16]
and four from human. TB3-1 clone was isolated from a hu-
man carcinoma cell line [17], clone 58 from a normal human
duodenal mucosa cDNA library [18], and HSCl1DHG7 and
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HSCl1DHG11 from a human Daudi cell line [16]. By using
human-mouse somatic cell panel analysis, TB3-1-related se-
quences were localised to human chromosomes 5, 6, 7 and
X [19]. Hybridisation of a human genomic Southern blot
with clone 58 displayed four HindIII intense bands of about
14, 13, 12 and 8.6 kb [20]. The genomic organisation of these
four human eRF1 homologous sequences remains unknown,
however.
In this paper, we describe the molecular cloning and the
structural organisation of the four human eRF1 homologous
sequences. We report evidence that only the gene localised on
chromosome 5 exhibits a typical exon-intron organisation,
and suggest that this is probably the unique functional gene.
2. Materials and methods
2.1. Cosmids
b Cosmid ICRFc104C2049: ICRF chromosome X-speci¢c cosmid
library, Resource Centre Primary Database, RZPD.
b Cosmid ICRFc109F1245: ICRF chromosome 6-speci¢c cosmid li-
brary, Resource Centre Primary Database, RZPD.
b Cosmid ICRFc113B1812Q4: ICRF chromosome 7-speci¢c cosmid
library, Resource Centre Primary Database, RZPD; cosmid
Y33B20: LLNL chromosome 7-speci¢c cosmid library, UK
HGMP Resource Centre.
b Cosmid 48G4 and cosmid 239D3: chromosome 5-speci¢c cosmid
library constructed at the Center for Human Genome Studies, Los
Alamos National Laboratory, Los Alamos, NM, USA, under the
auspices of the US Department of Energy.
2.2. Probes
The following probes were used after labelling with [K-32P]dCTP by
the random priming method [21].
b Clone 58: a 1548-bp clone isolated from a cDNA library of human
duodenal mucosa [12] and described as HSHCGVII (X80916) [20].
This sequence is identical to HSCl1DHG7 (X81625) from nucleo-
tide 765 to nucleotide 2313.
b Three other probes were obtained by polymerase chain reaction
(PCR) using Promega Taq DNA polymerase and the human
cDNA clone Cl1DHG7 (kindly given by M. Kress) as target
DNA: DHG7-A, 334 bp (position 120^453: forward, 5P-AGGAG-
GAGGCGAGAAGAT-3P, reverse, 5P-CTTTCCTTCTTCTGTT-
AC-3P), DHG7-B, 160 bp (position 534^693: forward, 5P-
AGAGGCTCTTACAGCACTAC-3P, reverse, 5P-TGACTGACC-
TCCTCTACCGTG-3P), DHG7-C, 809 bp (position 2376^3184:
forward, 5P-TGTGTTTCCTTGTGTTGG-3P, reverse, 5P-AAGC-
AAAAAAAGCCTGTTC-3P).
b M-5: a cDNA fragment of 257 bp, obtained by PCR using a mur-
ine cDNA clone (I.M.A.G.E. Consortium clone ID 1050740,
LNLN, HGMP Resource Center) as target DNA and the following
primers: forward, 5P-GGATCCTTGGGAGGAAGTGAG-3P (posi-
tion 3) reverse, 5P-GGCCCGCCTCCAAGCTCTTAAT-3P (posi-
tion 249). This probe is 97% identical to the ¢rst 217 nucleotides
of the human HSCl1DHG7 cDNA and contains 43 additional nu-
cleotides upstream.
2.3. Library screening
The chromosome-speci¢c cosmid libraries were screened with 50 ng
of clone 58 probe labelled with [K-32P]dCTP, in the presence of 50 ng
of the appropriate cosmid vector labelled with [35S]dATPKS. Positive
clones were puri¢ed by a secondary screening.
2.4. Restriction analysis of cosmid clones
Cosmid DNA, single (BamHI, HindIII, EcoRI, EcoRV, XbaI, XhoI)
or double (BamHI+HindIII, BamHI+EcoRI, BamHI+EcoRV, Hin-
dIII+EcoRI, HindIII+EcoRV, EcoRI+EcoRV) digested, was size-frac-
tionated by electrophoresis in 0.7% agarose gel, and the DNA frag-
ments were transferred to Hybond N (Amersham) according to the
standard procedure for Southern blotting [22]. Blots were successively
hybridised with several 32P-labelled probes: clone 58, DHG7-A,
DHG7-B and the appropriate vector. Restriction maps for each cos-
mid were elaborated and DNA fragments of interest were subcloned
in pBluescript II KS for sequencing.
2.5. DNA sequencing and computer analysis
DNA fragments were sequenced twice on both strands [23] using
dRhodamine terminator cycle sequencing kit (Perkin Elmer) and an
ABI 377 DNA sequencer. Sequence data were analysed using Se-
quencing Analysis, version 3.2 (ABI), and sequence assembly was
performed using SeqMan (DNASTAR). Various search tools were
also used: BLAST (NCBI, Bethesda, MD, USA), CENSOR [24].
3. Results
3.1. The human chromosome 6 eRF1 gene
Screening of the ICRF chromosome 6-speci¢c cosmid li-
brary with clone 58 probe yielded three positive clones. Hy-
bridisation with the same probe of a Southern blot of each
cosmid DNA cut with HindIII revealed a 12-kb fragment.
DNA fragments of interest were identi¢ed by restriction anal-
ysis using clone 58 probe and three other probes (DHG7-A,
DHG7-B and DHG7-C), then subcloned and sequenced. A
8170-bp genomic sequence was obtained and compared with
HSCl1DHG7 cDNA sequence (B. Chauvel, personal commu-
nication). The human chromosome 6 eRF1 gene sequence
lacked the ¢rst 457 nucleotides of the cDNA, as well as the
last 1360 nucleotides of the 3P UTR, and showed a 302-bp
insertion (Fig. 1A). There was only 95% identity between the
cDNA sequence and the corresponding genomic sequence,
and in view of the absence of GT/AG splice sites, it is prob-
able that the inserted region does not correspond to an intron.
A 356-kb sequence in the MHC class I region of chromosome
6, including the eRF1 gene, has now been achieved (GenBank
AF055066). Neither the ¢rst 457 nucleotides nor the last 1360
nucleotides of the cDNA were found in this sequence, how-
ever.
3.2. The human chromosome X eRF1 gene
Four positive clones were isolated by screening the ICRF
chromosome X-speci¢c cosmid library with clone 58 as a
probe. Digesting these clones by HindIII followed by hybrid-
isation with clone 58 revealed a 13-kb fragment for two of
them; one of the two cosmids (104C2049) was partly se-
quenced. Comparison of the resulting 8635-bp sequence with
that of HSCl1DHG7 cDNA revealed that the ¢rst 275 nucleo-
tides of the cDNA were absent, whilst a 331-nucleotide se-
quence had been inserted (Fig. 1B). In order to verify the
absence of the 5P part of the cDNA sequence, the 5P extended
probe (M-5 probe) was used to screen the chromosome X-
speci¢c cosmid library, but it revealed no positive clone. There
was only 92% nucleotide identity between the cDNA and the
human chromosome X eRF1 gene. The sequence has been
deposited in the GenBank database under accession number
AF110131.
3.3. The human chromosome 7 eRF1 gene
Two positive clones were obtained from screening of the
ICRF chromosome 7-speci¢c cosmid library with clone 58
probe and three positive clones from screening of the LLNL
chromosome 7-speci¢c cosmid library. Southern blot of Hin-
dIII-digested cosmid DNA hybridised with clone 58 showed a
unique 8.6-kb fragment. Cosmid 113B1812Q4 (ICRF) and
cosmid Y33B20 (LLNL) were partly sequenced using primers
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designed from the human HSCl1DHG7 cDNA. The resulting
3521-bp sequence was compared with the cDNA sequence. A
306-nucleotide region was inserted in the genomic sequence,
whilst the last 1360 nucleotides of the 3P UTR were missing
(Fig. 1C). The DHG7-C probe, corresponding to a 809-bp
DNA fragment of the 3P UTR, gave no positive signal after
hybridisation with the library ¢lters, indicating that the hu-
man chromosome 7 eRF1 gene sequence stopped a few nu-
cleotides downstream of the polyadenylation site AATAAA,
as did that on chromosome 6. There was nearly 95% nucleo-
tide identity between the cDNA and the corresponding ge-
nomic sequence, but numerous deletions of up to 40 nucleo-
tides in length occurred on chromosome 7. The sequence has
been deposited in the GenBank database under accession
number AF112357.
3.4. The human chromosome 5 eRF1 gene
A chromosome 5-speci¢c cosmid library constructed at the
Center for Human Genome Studies (LANL) was screened
with clone 58 probe and gave 13 positive clones, one of
them (48G4) being positive also for M-5 probe. A Southern
blot of the 13 cosmid DNA cut by HindIII and hybridised
with clone 58 showed a unique band of 6.7 kb; although the
HindIII fragment size was not as anticipated (14 kb), the
analysis was continued. One cosmid, 239D3, positive for clone
58 alone, and the cosmid 48G4 positive for the two probes,
were entirely sequenced. Comparison of the resulting 50 769-
bp sequence with the cDNA sequence showed that the entire
sequence of the human HSCl1DHG7 cDNA was retrieved.
By comparing the nucleotide sequence of the human chro-
mosome 5 eRF1 gene and HSCl1DHG7 cDNA, we deduced
Fig. 1. Alignment of the human cDNA HSCl1DHG7 sequence and the eRF1 gene sequences on chromosome 6 (A), chromosome X (B) and
chromosome 7 (C). Homologous regions between the cDNA and the genomic sequences are presented as solid boxes. cDNA sequences absent
from the genomic sequences are shown as open boxes. The nucleotide identity between cDNA and genomic sequences is indicated for each
chromosome in %. The position and the name of the di¡erent probes are indicated in A as black bars.
Fig. 2. Genomic organisation of the human chromosome 5 eRF1 gene. Untranslated exons are depicted as open and translated ones as closed
boxes, lines represent introns. The translation start codon, the stop codon and the two polyadenylation sites are indicated. Restriction enzyme
sites: RI, EcoRI; H, HindIII.
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the exon/intron organisation of the gene, encompassing 11
exons and 10 introns (Fig. 2). This genomic sequence was
deposited in the GenBank database under accession number
AF095901. As shown in Table 1, all exon-intron boundaries
conform to consensus donor-acceptor sequences (gt/ag). The
intron splice phasing is type 0 (the intron is located between
codons) for intron 1, 4, 6 and 9, type 1 (the intron interrupts
the ¢rst and second bases of the codon) for introns 3, 5, 7, 8
and 10, and type 2 (the intron interrupts the second and third
bases of the codon) for intron 2. The intron size ranged from
160 to 23 582 bp, the largest being located between exons 2
and 3. The exons range from 65 bp for exon 9 to 2289 bp for
exon 11 which contains a long 3P UTR region. The ¢rst exon
only contains untranslated sequence, exon 2 comprises the
ATG initiation codon, and the TAG stop codon is located
in exon 11. The two polyadenylation sites AATAAA and
ATTAAA found in positions 2289 and 3637 respectively of
the cDNA sequence, are also present in the 3P UTR of exon
11. There are di¡erences between the exonic and the cDNA
sequences: an additional G is found in the untranslated exon
1 (between nucleotides 67 and 68 of the cDNA), two addi-
tional nucleotides T and C also occur in the 3P UTR (between
nucleotides 2382 and 2383 and nucleotides 2719 and 2720
respectively), and a GCT change (position 2655 of the
cDNA) in the 3P UTR gives a HindIII polymorphism site.
That polymorphism generates two allelic fragments of 14
Table 1
Exon-intron organisation of the human chromosome 5 eRF1 gene
Exon number Exon size (bp) 5P Splice donor Intron number Intron size (bp) 3P Splice acceptor
1 118 GGC CCT TAG gtaaggc 1 160 gctctag GGA GGA GGA
2 104 GCG GCC CGC GG gtgagcg 2 23582 tccacag C AAT GGC ACC
3 176 TAT AAC AAA G gtaatct 3 992 tttgcag TA CCT CCA AAT
4 140 CAT ACA GAG gtaagaa 4 3854 ttttcag GCT CTT ACA
5 139 AAG AAA CAC G gtaatac 5 613 gtcaaag GT AGA GGA GGT
6 191 TTT GAT CAG gtaagta 6 1160 gtgttag AGG TTA CAA
7 130 AAA TTA ATA G gtatcgg 7 274 atcgtag GA CGA TAC TTT
8 156 GGC ACA GAA G gtatgag 8 415 actacag AG GAG AAA ATT
9 65 GAC AAA GAG gtatgtg 9 1748 cctgtag ACC GGA CAG
10 148 GGA ATT GGA G gtgagta 10 281 tccccag GT ATC TTG CGG
11 2289
Fig. 3. Nucleotide sequence of portions of 5P £anking chromosome 5 genomic DNA, the ¢rst exon, the ¢rst intron and proximal part of exon
2. Exon sequences are in boldface, the translation start site ATG is framed, the eukaryote Pol II putative promoter sequence is dot underlined
and the predicted transcription factors binding sites are underlined with their names written below.
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and 6.7 kb, the smaller being present on the cosmid DNA
studied. The average allelic frequency in a normal population
for the minor allele (6.7 kb) is about 4%.
The 5P-end £anking region (5040 bp long) was searched for
putative promoters [25] and analysed for consensus factor
binding motifs [26]. The sequence between positions 4356
and 5384 is GC-rich (65%), with an observed/expected ratio
of CpG dinucleotides estimated to be 0.75 [27]. This region
contains several predicted sequences that may function as Sp1
and Sp1-like protein binding sites and a putative eukaryote
Pol II promoter region (4636^4885), but does not contain a
canonical TATA or CCAAT box (Fig. 3). In addition, other
potential regulatory elements are also present, including
GATA, NF1, CTF and CREB.
4. Discussion
In this study, we report the cloning, sequencing and char-
acterisation of the human eRF1 gene family, which contains
four homologous sequences located on chromosomes 5, 6, 7
and X. The main point that emerges from this analysis is that
only the gene present on chromosome 5, which corresponds to
the SUP45L1 gene (as de¢ned by the HUGO/GDB nomen-
clature committee), seems to be functional, whereas the three
other sequences (SUP45L2 on chromosome 6, SUP45L3 on
chromosome 7, SUP45L4 on chromosome X) look like non-
functional copies of exonic sequences of the eRF1 gene.
These homologous sequences found on chromosomes 6, 7
and X accumulate base substitutions, small deletions and in-
sertions, and nucleotide identity with HSCl1DHG7 cDNA
sequence is only 95%, 95% and 92% respectively. Although
each contains an inserted sequence and lacks a 3P-end A-
stretch, these sequences may correspond to truncated proc-
essed pseudogenes. Such interspersed multigene families con-
taining one or more functional genes and many processed
pseudogenes are known, but there is no apparent evolutionary
advantage in the addition of transcriptionally inactive gene
copies. The signi¢cance of these three processed pseudogenes
remains unknown.
As a consequence, only the gene located on chromosome 5
displays the organisation of a functional gene. Nucleotide
identity between exonic sequences and cDNA HSCl1DHG7
is 99.9%. The gene spans approximately 40 kb and consists of
11 exons, the ¢rst untranslated, and 10 introns. A very long
intron (23 582 bp) is located between exons 2 and 3. Upstream
of the ATG, a 1100-bp sequence lacks repetitive elements and
contains potential regulatory elements. Another region, 2900
bp long, downstream of exon 2 and corresponding to the
proximal part of the large intron, also lacks repetitive ele-
ments and may play an important part in transcriptional reg-
ulation. A putative promoter sequence is predicted, without a
TATA box, which is a major characteristic of housekeeping
genes. This is consistent with the fact that eRF1 transcripts
were detected by Northern blot analysis in a wide range of
mammalian tissues [16,20], which suggests that the expression
of eRF1 gene is essential for the function of most (or all)
types of cells. Somewhat di¡erent results are found in the
literature concerning the expression of eRF1 gene. Two tran-
scripts of 3.6 and 2.2 kb were found in all of the tissues tested,
the shorter of these in much lower abundance [16], whereas
others [20] mentioned two major transcripts of about 4 and
2.8 kb and two minor transcripts of about 2 and 1.4 kb, with
varying relative expression of the two major transcripts, de-
pending on the tissue tested. Whatever the exact size of these
two major transcripts, it is consistent with the two identi¢ed
human cDNAs and the position of the two polyadenylation
sites [16]. Alternative splicing regulation or alternative pro-
moters have to be considered. Knowledge of the complete
gene structure and of the 5P £anking genomic sequence will
allow the functional characterisation of the promoter region
and of the transcription factors, and will therefore provide
understanding of the mechanisms involved in expression at
the transcriptional level.
There is a remarkably high degree of amino acid identity
between members of the eRF1 protein family from yeast Sac-
charomyces cerevisiae (Sup45p) to human [4,16]. That se-
quence conservation corresponds to a functional conservation
[16] : in fact, it has been demonstrated that either mammalian
or amphibian eRF1 cDNA can replace the endogenous
SUP45 gene in yeast with respect to its activity in translation
termination and cell viability. Thus eRF1gene has successfully
resisted a high selection pressure which is consistent with its
indispensable function to the survival of the members of eu-
karyotic species during evolution.
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